Interesting research being undertaken by Barbara Guinn, Head of Biomedical Sciences, University of Hull in The Conversation.com. “A urine test for ovarian cancer could increase survival rates from 20% to 90%.” This is why it’s so important that the quality of specimens allows for right-first-time diagnosis and that appropriate treatment follows.
On 11th September, delegates from microbiology, patient safety, urology, Emergency and antenatal medicine gathered at the RCP, London to hear Forte Medical Forum speakers and panel discuss the value of accurate diagnoses. Well, they didn’t just listen, many took part as the Q&A session evolved into a lively conversation about urine; believe me, there were […]
URINE TROUBLE: HOW POOR COLLECTION STANDARDS ARE FAILING MODERN MEDICINE 11th September 2018 at the Royal College of Physicians, London Despite mounting evidence to support the need for a respected protocol, incumbent methods are failing modern medicine, patient health and the work of diligent clinicians. With the Rt Hon Matt Hancock MP highlighting ‘Prevention’ and ‘Technology’ as […]
The NHS National Institute for Health Research (NIHR) will be holding their national industry event on 10th October and our CEO, Giovanna Forte will be participating in the session focusing on “Maximising Our Medtech Might”. The theme for this year’s event is: The Future Now and provides a platform to discuss the latest developments and opportunities in […]
This is the latest recommendation following publication of a Californian study about the rise of antibiotic-resistant bacteria. But right-first-time diagnosis and treatment is only possible if the urine sample is collected correctly in the first place. In the UK, nearly 1 in 3 women will have a UTI by the time they are 24 and […]
A new study shows that Antibiotic-resistant UTI bacteria is becoming more common; Knowlex has created a short-film about the research and what you should know about this worrying dilemma. 49% of AMR increase has a urinary source. Health policy makers must stop overlooking basic specimen collection and create a protocol for use. Read the […]
We’ve been an advocate for the MUST Campaign since they launched in May and this article explains why it is so important. Read about it in this article published today on AgeSpace.com
The inaugural speech delivered by Mr Matt Hancock upon his appointment as Secretary of State for Health, focused quite rightly on the acceleration of preventative practice and the adoption of novel technology. Forte Medical welcomes this approach … if it happens. It is high time to highlight and seriously consider the problems behind historic innovation adoption across the […]
The success of the ABHI’s Innovation Hub at the Dell Medical School at the University of Texas in Austin is growing and it is case studies such as ours published this month that is helping demonstrate the importance of the Association’s work in building opportunities for British companies. Read our story here.
This week saw the launch of Forte Medical’s Series A investment round for growth, export and new product development. Seeking £3.5m, the company is engaging with prospective investment partners who can attract investors with an interest in evidenced, disruptive diagnostic medical devices with digital potential. Institutional, corporate or personal investors who can assist the business […]